Drug distributors and Johnson & Johnson will pay $26bn as America’s biggest opioid settlement is finalised Post date 1 March 2022 ← When I use a word . . . . Bioscience journals—an open and shut case? → Cracking delayed discharges will need local innovation and bold national action